Clin2
NCT06704685Possibly a fitNot yet recruiting

Butylphthalide for heart attack patients after stent placement

ST-segment Elevation Myocardial Infarction (STEMI)

Treatments studied

Part of Heart & circulation clinical trials.

This trial tests if adding butylphthalide to standard care can reduce heart muscle damage in people having a major heart attack (STEMI) who are getting a stent. It aims to improve recovery and outcomes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
40 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You are having a first-time major heart attack (STEMI) and can get a stent within 12 hours of pain starting.
  • You have not had a previous heart stent or bypass surgery.
  • You are not on long-term blood thinners or antiplatelet drugs at high doses.
  • You are not currently pregnant, breastfeeding, or planning pregnancy within 30 days.
  • You do not have severe bleeding risk, recent stroke, or other serious illnesses.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06331494Not yet recruiting
Testing butylphthalide for blocked brain arteries

This trial tests if butylphthalide, a drug that may improve blood flow, helps people with a narrowed artery in the brain (the middle cerebral artery) after a recent stroke or mini-stroke. It is for people aged 55-75 with at least one risk factor like high blood pressure or diabetes.

Guangzhou, Guangdong
NCT07528456Not yet recruiting· Phase 4
Butylphthalide to Reduce Brain Swelling After Stroke Treatment

This trial tests whether a medication called butylphthalide can help reduce brain swelling that sometimes occurs after emergency endovascular treatment (a minimally invasive procedure to restore blood flow) for certain types of stroke.

Dongguan, Guangdong
NCT06353334Recruiting· Phase 4
Butylphthalide for brain recovery after cardiac arrest

This trial tests if butylphthalide can improve brain function in people who have been resuscitated after a cardiac arrest. It may help reduce brain damage and improve recovery.

Beijing, Beijing Municipality
NCT07369999Recruiting· Phase 3
Butylphthalide plus tenecteplase for mild disabling stroke

This trial tests whether adding butylphthalide (a drug that improves blood flow) to the standard clot-busting medicine tenecteplase can help people with mild but disabling strokes recover better. If you have had a mild stroke within the last 4.5 hours and are 18–80, this study might be an option for you.

Changsha, Hunan
NCT07230587Not yet recruiting· Phase 3
Butylphthalide for memory after mild stroke

This trial tests if butylphthalide, a medicine given by mouth, can help prevent long-term thinking and memory problems after a minor stroke. It is for people who had a very mild stroke and enrolled soon after.

NCT06572085Recruiting· Phase 4
Butylphthalide for brain protection after cardiac arrest

This trial tests a medicine called butylphthalide (NBP) to see if it helps protect the brain after a cardiac arrest. It is for adults who remained unconscious after their heart was restarted.

Beijing, Beijing Municipality

Hear when a new ST-segment Elevation Myocardial Infarction (STEMI) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.